Question 1

What is Chemed's deferred tax assets implicit price concessions?

Accepted Answer

Chemed (CHE) reported deferred tax assets implicit price concessions of $5.23M in Q4 2025.

Question 2

How has Chemed's deferred tax assets implicit price concessions changed year-over-year?

Accepted Answer

Chemed's deferred tax assets implicit price concessions decreased by 35.5% year-over-year, from $8.12M to $5.23M.

Question 3

What is the long-term trend for Chemed's deferred tax assets implicit price concessions?

Accepted Answer

Over 5 years (2020 to 2025), Chemed's deferred tax assets implicit price concessions has grown at a -5.7% compound annual growth rate (CAGR), from $7.03M to $5.23M.

Question 4

What does deferred tax assets implicit price concessions mean?

Accepted Answer

This represents the deferred tax asset arising from the difference between revenue recognized for financial reporting and the amount expected to be collected, specifically accounting for implicit price concessions. It reflects the tax impact of adjusting revenue estimates for expected credit losses or contractual adjustments. This metric helps in understanding the tax implications of revenue recognition policies and collection risks.

Line item	December 31, 2025	December 31, 2024
Accrued liabilities	$$45,738	42,411
Lease liabilities	34,613	33,982
Stock compensation expense	13,017	11,229
Implicit price concessions	5,234	8,115
State net operating loss carryforwards	2,384	1,839
Other	836	1,214
Deferred income tax assets	101,822	98,790
Amortization of intangible assets	(45,259)	(42,754)

Deferred Tax Assets Implicit Price Concessions at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Chemed's deferred tax assets implicit price concessions.

Chemed CHE Deferred Tax Assets Implicit Price Concessions